Insider Trading › ENDP › Insiders
ENDP
ENDP·Insider activity
—
No end-of-day price on record
ENDP
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ENDPS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of ENDP were filed in the last 180 days. Newest filing Mar 16, 2021 (5 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by ENDP insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
154Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of ENDP common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
154 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| MONTAGUE WILLIAM PDirector | Sale | −9,033 | $8.68 | $78K | 97.1Kdirect | Mar 15, 2021 | Mar 16, 2021 | Form 4 ↗ |
| Cooke ShaneDirector | Sale | −17.3K | $8.65 | $150K | 77.0Kdirect | Mar 15, 2021 | Mar 15, 2021 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −30.0K | $4.09 | $123K | 80.0Kindirect | Sep 16, 2019 | Sep 17, 2019 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −25.0K | $4.09 | $102K | 123.3Kdirect | Sep 16, 2019 | Sep 17, 2019 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −10.0K | $3.93 | $39K | 110.0Kindirect | Jun 17, 2019 | Jun 19, 2019 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −25.0K | $3.93 | $98K | 148.3Kdirect | Jun 17, 2019 | Jun 19, 2019 | Form 4 ↗ |
| MONTAGUE WILLIAM PDirector | Sale | −10.0K | $11.41 | $114K | 64.9Kdirect | Dec 10, 2018 | Dec 10, 2018 | Form 4 ↗ |
| Hutson Nancy JDirector | Sale | −10.0K | $12.83 | $128K | 50.0Kdirect | Nov 15, 2018 | Nov 16, 2018 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −14.0K | $15.90 | $223K | 120.0Kindirect | Aug 14, 2018 | Aug 15, 2018 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −12.1K | $15.90 | $192K | 145.3Kdirect | Aug 14, 2018 | Aug 15, 2018 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −4,000 | $6.90 | $28K | 136.1Kindirect | Nov 15, 2017 | Nov 17, 2017 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −5,134 | $6.90 | $35K | 138.9Kdirect | Nov 15, 2017 | Nov 17, 2017 | Form 4 ↗ |
| Maletta Matthew JosephEVP, Chief Legal Officer | Purchase | +3,000 | $8.02 | $24K | 6,984direct | Aug 15, 2017 | Aug 15, 2017 | Form 4 ↗ |
| Coleman BlaiseEVP, Chief Financial Officer | Purchase | +6,500 | $7.89 | $51K | 13.7Kdirect | Aug 15, 2017 | Aug 15, 2017 | Form 4 ↗ |
| Campanelli PaulPresident, CEO · Director | Purchase | +6,500 | $7.71 | $50K | 213.6Kdirect | Aug 14, 2017 | Aug 15, 2017 | Form 4 ↗ |
| Coughlin Terrance JEVP, Chief Operating Officer | Purchase | +20.0K | $7.70 | $154K | 140.6Kdirect | Aug 10, 2017 | Aug 11, 2017 | Form 4 ↗ |
| Campanelli PaulPresident, CEO · Director | Purchase | +2,300 | $10.72 | $25K | 207.1Kdirect | Mar 16, 2017 | Mar 16, 2017 | Form 4 ↗ |
| Hutson Nancy JDirector | Sale | −5,325 | $10.82 | $58K | 31.3Kdirect | Mar 9, 2017 | Mar 10, 2017 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −50 | $18.21 | $911 | 188.0Kindirect | Nov 15, 2016 | Nov 16, 2016 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −6,950 | $17.37 | $121K | 188.1Kindirect | Nov 15, 2016 | Nov 16, 2016 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −50 | $18.21 | $911 | 68.4Kdirect | Nov 15, 2016 | Nov 16, 2016 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −6,950 | $17.37 | $121K | 68.4Kdirect | Nov 15, 2016 | Nov 16, 2016 | Form 4 ↗ |
| HIGGINS ARTHUR JDirector | Purchase | +5,000 | $13.80 | $69K | 50.6Kdirect | May 11, 2016 | May 12, 2016 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Purchase | +5,000 | $15.48 | $77K | 195.0Kindirect | May 10, 2016 | May 11, 2016 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Purchase | +2,000 | $15.66 | $31K | 75.4Kdirect | May 10, 2016 | May 11, 2016 | Form 4 ↗ |
| HIGGINS ARTHUR JDirector | Purchase | +11.0K | $15.42 | $170K | 45.6Kdirect | May 10, 2016 | May 11, 2016 | Form 4 ↗ |
| Campanelli PaulGroup President, Generics | Purchase | +13.0K | $15.53 | $202K | 201.1Kdirect | May 10, 2016 | May 11, 2016 | Form 4 ↗ |
| INGRAM DOUGLAS SDirector | Sale Amended | −4,513 | $26.59 | $120K | 4,890direct | May 5, 2016 | May 18, 2016 | Form 4 ↗ |
| Spengler WilliamDirector | Purchase | +1,000 | $29.20 | $29K | 48.8Kdirect | Mar 17, 2016 | Mar 17, 2016 | Form 4 ↗ |
| Spengler WilliamDirector | Purchase | +1,000 | $35.24 | $35K | 47.8Kdirect | Mar 16, 2016 | Mar 16, 2016 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Purchase | +1,125 | $41.94 | $47K | 73.4Kdirect | Mar 14, 2016 | Mar 14, 2016 | Form 4 ↗ |
| Maletta Matthew JosephExec. V.P.,Chief Legal Officer | Purchase | +500 | $44.48 | $22K | 1,000direct | Mar 7, 2016 | Mar 7, 2016 | Form 4 ↗ |
| DE SILVA RAJIVPresident & CEO · Director | Purchase | +2,250 | $44.50 | $100K | 250.7Kdirect | Mar 7, 2016 | Mar 7, 2016 | Form 4 ↗ |
| MONTAGUE WILLIAM PDirector | Sale Amended | −3,413 | $42.19 | $144K | 39.2Kdirect | Mar 1, 2016 | Apr 21, 2016 | Form 4 ↗ |
| Spengler WilliamDirector | Sale | −3,413 | $42.19 | $144K | 46.8Kdirect | Mar 1, 2016 | Mar 3, 2016 | Form 4 ↗ |
| Smith Jill D.Director | Sale | −3,413 | $42.19 | $144K | 19.8Kdirect | Mar 1, 2016 | Mar 3, 2016 | Form 4 ↗ |
| HYATT MICHAELDirector | Sale | −3,413 | $42.19 | $144K | 250.3Kdirect | Mar 1, 2016 | Mar 3, 2016 | Form 4 ↗ |
| Hutson Nancy JDirector | Sale | −3,413 | $42.19 | $144K | 36.6Kdirect | Mar 1, 2016 | Mar 3, 2016 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Purchase | +841 | $57.00 | $48K | 108.4Kdirect | Nov 16, 2015 | Nov 17, 2015 | Form 4 ↗ |
| Cooke ShaneDirector | Purchase | +4,000 | $57.13 | $229K | 10.2Kdirect | Nov 12, 2015 | Nov 12, 2015 | Form 4 ↗ |
| Maletta Matthew JosephExec. V.P.,Chief Legal Officer | Purchase | +500 | $56.19 | $28K | 500direct | Nov 11, 2015 | Nov 12, 2015 | Form 4 ↗ |
| Lortie BrianPresident Branded Pharma | Purchase | +700 | $56.47 | $40K | 17.5Kdirect | Nov 11, 2015 | Nov 12, 2015 | Form 4 ↗ |
| HYATT MICHAELDirector | Sale | −8,000 | $55.48 | $444K | 251.6Kdirect | Nov 11, 2015 | Nov 12, 2015 | Form 4 ↗ |
| Hall SusanEVP, CSO, Global Head of R&D | Purchase | +1,000 | $55.35 | $55K | 2,666direct | Nov 11, 2015 | Nov 12, 2015 | Form 4 ↗ |
| Upadhyay SuketuEVP, Chief Financial Officer | Purchase | +3,450 | $56.68 | $196K | 15.9Kdirect | Nov 11, 2015 | Nov 12, 2015 | Form 4 ↗ |
| Upadhyay SuketuEVP, Chief Financial Officer | Purchase | +1,000 | $55.31 | $55K | 12.4Kdirect | Nov 11, 2015 | Nov 12, 2015 | Form 4 ↗ |
| Campanelli PaulPresident, Par Pharmaceutical | Purchase | +200 | $56.38 | $11K | 188.1Kdirect | Nov 11, 2015 | Nov 12, 2015 | Form 4 ↗ |
| Campanelli PaulPresident, Par Pharmaceutical | Purchase | +1,900 | $55.62 | $106K | 187.9Kdirect | Nov 11, 2015 | Nov 12, 2015 | Form 4 ↗ |
| DE SILVA RAJIVPresident & CEO · Director | Purchase | +9,006 | $55.52 | $500K | 181.4Kdirect | Nov 11, 2015 | Nov 12, 2015 | Form 4 ↗ |
| HIGGINS ARTHUR JDirector | Purchase | +2,500 | $81.10 | $203K | 22.8Kdirect | Jun 16, 2015 | Jun 18, 2015 | Form 4 ↗ |
| MANOGUE CAROLINE BExec. V.P.,Chief Legal Officer | Sale | −105.1K | $91.90 | $9.7M | 43.1Kdirect | Apr 8, 2015 | Apr 9, 2015 | Form 4 ↗ |
| MANOGUE CAROLINE BExec. V.P.,Chief Legal Officer | Sale | −503 | $91.90 | $46K | 43.1Kdirect | Apr 7, 2015 | Apr 9, 2015 | Form 4 ↗ |
| Farhat CamillePresident, AMS, Inc. | Sale | −8,650 | $89.39 | $773K | 0direct | Mar 10, 2015 | Mar 12, 2015 | Form 4 ↗ |
| Farhat CamillePresident, AMS, Inc. | Sale | −40.4K | $87.02 | $3.5M | 8,650direct | Mar 9, 2015 | Mar 11, 2015 | Form 4 ↗ |
| MANOGUE CAROLINE BExec. V.P.,Chief Legal Officer | Sale | −42.0K | $87.78 | $3.7M | 43.1Kdirect | Mar 5, 2015 | Mar 9, 2015 | Form 4 ↗ |
| Lortie BrianPresident Branded Pharma | Sale | −5,800 | $85.35 | $495K | 16.8Kdirect | Mar 4, 2015 | Mar 6, 2015 | Form 4 ↗ |
| Upadhyay SuketuEVP, Chief Financial Officer | Purchase | +3,700 | $66.94 | $248K | 7,222direct | Nov 14, 2014 | Nov 18, 2014 | Form 4 ↗ |
| HIGGINS ARTHUR JDirector | Purchase | +3,500 | $65.65 | $230K | 8,827direct | Aug 5, 2014 | Aug 7, 2014 | Form 4 ↗ |
| DELUCCA JOHNDirector | Sale | −6,764 | $68.83 | $466K | 28.1Kdirect | Jun 9, 2014 | Jun 10, 2014 | Form 4 ↗ |
| MANOGUE CAROLINE BExec. V.P., CLO & Secy | Sale | −175.0K | $72.02 | $12.6M | 34.6Kdirect | May 29, 2014 | Jun 2, 2014 | Form 4 ↗ |
| DELUCCA JOHNDirector | Sale | −8,094 | $66.31 | $537K | 21.6Kdirect | May 1, 2014 | May 2, 2014 | Form 4 ↗ |
| DELUCCA JOHNDirector | Sale | −10.4K | $68.46 | $711K | 21.6Kdirect | Apr 1, 2014 | Apr 2, 2014 | Form 4 ↗ |
| Hutson Nancy JDirector | Sale | −5,000 | $72.12 | $361K | 20.5Kdirect | Mar 10, 2014 | Mar 11, 2014 | Form 4 ↗ |
| HIGGINS ARTHUR JDirector | Purchase | +5,000 | $73.00 | $365K | 5,000direct | Mar 10, 2014 | Mar 11, 2014 | Form 4 ↗ |
| Gergel Ivan P.EVP, R&D and CSO | Sale | −6,607 | $72.47 | $479K | 27.6Kdirect | Mar 10, 2014 | Mar 11, 2014 | Form 4 ↗ |
| Gergel Ivan P.EVP, R&D and CSO | Sale | −22.1K | $72.47 | $1.6M | 27.6Kdirect | Mar 10, 2014 | Mar 11, 2014 | Form 4 ↗ |
| Gergel Ivan P.EVP, R&D and CSO | Sale | −31.2K | $72.47 | $2.3M | 27.6Kdirect | Mar 10, 2014 | Mar 11, 2014 | Form 4 ↗ |
| Gergel Ivan P.EVP, R&D and CSO | Sale | −15.7K | $72.47 | $1.1M | 27.6Kdirect | Mar 10, 2014 | Mar 11, 2014 | Form 4 ↗ |
| MANOGUE CAROLINE BExec. V.P., CLO & Secy | Sale | −15.6K | $39.40 | $614K | 46.4Kdirect | Aug 26, 2013 | Aug 27, 2013 | Form 4 ↗ |
| MANOGUE CAROLINE BExec. V.P., CLO & Secy | Sale | −130.0K | $39.40 | $5.1M | 62.0Kdirect | Aug 26, 2013 | Aug 27, 2013 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Purchase | +5,478 | $36.50 | $200K | 51.9Kdirect | Aug 8, 2013 | Aug 9, 2013 | Form 4 ↗ |
| Gergel Ivan P.EVP, R&D and CSO | Sale | −33.0K | $36.41 | $1.2M | 0direct | Apr 24, 2013 | Apr 26, 2013 | Form 4 ↗ |
| Gergel Ivan P.EVP, R&D and CSO | Sale | −31.5K | $36.48 | $1.1M | 33.0Kdirect | Apr 24, 2013 | Apr 26, 2013 | Form 4 ↗ |
| Gergel Ivan P.EVP, R&D and CSO | Sale | −61.2K | $36.46 | $2.2M | 33.0Kdirect | Apr 24, 2013 | Apr 26, 2013 | Form 4 ↗ |
| Gergel Ivan P.EVP, R&D and CSO | Sale | −12.5K | $36.48 | $456K | 33.0Kdirect | Apr 24, 2013 | Apr 26, 2013 | Form 4 ↗ |
| MANOGUE CAROLINE BExec. V.P., CLO & Secy | Sale | −35.0K | $35.00 | $1.2M | 62.0Kdirect | Apr 9, 2013 | Apr 11, 2013 | Form 4 ↗ |
| NASH DAVIDDirector | Purchase | +670 | $30.80 | $21K | 10.4Kdirect | Mar 5, 2013 | Mar 6, 2013 | Form 4 ↗ |
| Rudio DanielVice President, Controller | Sale | −520 | $30.91 | $16K | 526direct | Feb 28, 2013 | Mar 1, 2013 | Form 4 ↗ |
| Rudio DanielVice President, Controller | Sale | −322 | $29.88 | $10K | 526direct | Feb 27, 2013 | Mar 1, 2013 | Form 4 ↗ |
| Rudio DanielVice President, Controller | Sale | −448 | $29.88 | $13K | 526direct | Feb 27, 2013 | Mar 1, 2013 | Form 4 ↗ |
| Rudio DanielVice President, Controller | Sale | −482 | $28.10 | $14K | 526direct | Feb 21, 2013 | Feb 25, 2013 | Form 4 ↗ |
| Holveck DavidPresident & CEO · Director | Purchase | +7,425 | $26.84 | $199K | 31.5Kdirect | Nov 12, 2012 | Nov 14, 2012 | Form 4 ↗ |
| Rudio DanielVice President, Controller | Sale | −1,957 | $32.23 | $63K | 292direct | Aug 10, 2012 | Aug 14, 2012 | Form 4 ↗ |
| LEVIN ALAN GEVP, Chief Financial Officer | Purchase | +3,200 | $29.68 | $95K | 3,200direct | Jun 15, 2012 | Jun 19, 2012 | Form 4 ↗ |
| Holveck DavidPresident & CEO · Director | Purchase | +8,550 | $29.23 | $250K | 24.1Kdirect | Jun 12, 2012 | Jun 14, 2012 | Form 4 ↗ |
| HYATT MICHAELDirector | Sale | −5,000 | $32.31 | $162K | 0direct | Nov 8, 2011 | Nov 8, 2011 | Form 4 ↗ |
| Holveck DavidPresident & CEO · Director | Purchase | +8,200 | $30.30 | $248K | 15.5Kdirect | Aug 25, 2011 | Aug 26, 2011 | Form 4 ↗ |
| MANOGUE CAROLINE BExec. V.P., CLO & Secy | Sale | −20.6K | $41.17 | $848K | 0direct | Jul 6, 2011 | Jul 7, 2011 | Form 4 ↗ |
| Gergel Ivan P.EVP, Research & Development | Sale | −12.5K | $39.39 | $492K | 0direct | May 3, 2011 | May 4, 2011 | Form 4 ↗ |
| MANOGUE CAROLINE BExec. V.P., CLO & Secy | Sale | −35.0K | $39.90 | $1.4M | 0direct | Apr 5, 2011 | Apr 5, 2011 | Form 4 ↗ |
| Sweeney Edward JPrincipal Accounting Officer | Sale | −3,319 | $36.00 | $119K | 0direct | Mar 3, 2011 | Mar 7, 2011 | Form 4 ↗ |
| Sweeney Edward JPrincipal Accounting Officer | Sale | −5,760 | $36.00 | $207K | 0direct | Mar 3, 2011 | Mar 7, 2011 | Form 4 ↗ |
| Sweeney Edward JPrincipal Accounting Officer | Sale | −5,068 | $36.00 | $182K | 0direct | Mar 3, 2011 | Mar 7, 2011 | Form 4 ↗ |
| Sweeney Edward JPrincipal Accounting Officer | Sale | −4,612 | $36.25 | $167K | 0direct | Mar 3, 2011 | Mar 7, 2011 | Form 4 ↗ |
| Sweeney Edward JPrincipal Accounting Officer | Sale | −6,339 | $36.25 | $230K | 0direct | Mar 3, 2011 | Mar 7, 2011 | Form 4 ↗ |
| Sweeney Edward JPrincipal Accounting Officer | Sale | −1,292 | $36.00 | $47K | 0direct | Mar 3, 2011 | Mar 7, 2011 | Form 4 ↗ |
| Gergel Ivan P.EVP, Research & Development | Sale | −30.6K | $35.77 | $1.1M | 0direct | Mar 2, 2011 | Mar 3, 2011 | Form 4 ↗ |
| Sweeney Edward JPrincipal Accounting Officer | Sale | −1,110 | $35.11 | $39K | 0direct | Mar 1, 2011 | Mar 3, 2011 | Form 4 ↗ |
| Gergel Ivan P.EVP, Research & Development | Sale | −15.7K | $33.59 | $529K | 0direct | Feb 24, 2011 | Feb 25, 2011 | Form 4 ↗ |
| Sweeney Edward JPrincipal Accounting Officer | Sale | −695 | $32.34 | $22K | 0direct | Feb 21, 2011 | Feb 25, 2011 | Form 4 ↗ |
| Sweeney Edward JPrincipal Accounting Officer | Sale | −1,170 | $32.34 | $38K | 0direct | Feb 19, 2011 | Feb 25, 2011 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −13.7K | $36.55 | $502K | 191.9Kdirect | Dec 10, 2010 | Dec 13, 2010 | Form 4 ↗ |
| LEVIN ALAN GEVP, Chief Financial Officer | Sale | −16.6K | $36.04 | $599K | 6,577direct | Dec 7, 2010 | Dec 9, 2010 | Form 4 ↗ |
| Hutson Nancy JDirector | Purchase | +1,000 | $36.38 | $36K | 1,000indirect | Dec 7, 2010 | Dec 9, 2010 | Form 4 ↗ |
| HYATT MICHAELDirector | Sale | −10.0K | $36.43 | $364K | 247.6Kdirect | Dec 3, 2010 | Dec 7, 2010 | Form 4 ↗ |
| Gergel Ivan P.EVP, Research & Development | Sale | −30.6K | $36.53 | $1.1M | 0direct | Dec 3, 2010 | Dec 7, 2010 | Form 4 ↗ |
| Gergel Ivan P.EVP, Research & Development | Sale | −25.0K | $36.53 | $913K | 30.6Kdirect | Dec 3, 2010 | Dec 7, 2010 | Form 4 ↗ |
| Sweeney Edward JPrincipal Accounting Officer | Sale | −1,110 | $22.34 | $25K | 0direct | Mar 1, 2010 | Mar 2, 2010 | Form 4 ↗ |
| Sweeney Edward JPrincipal Accounting Officer | Sale | −695 | $21.69 | $15K | 1,110direct | Mar 1, 2010 | Mar 2, 2010 | Form 4 ↗ |
| Hutson Nancy JDirector | Purchase | +3,000 | $16.31 | $49K | 6,908direct | May 13, 2009 | May 18, 2009 | Form 4 ↗ |
| Holveck DavidPresident & CEO · Director | Purchase | +29.0K | $16.74 | $485K | 29.0Kdirect | Mar 10, 2009 | Mar 10, 2009 | Form 4 ↗ |
| SHAW DAVID E10% owner | Sale | −700.0K | $16.65 | $11.7M | 11.6Mdirect | Mar 9, 2009 | Mar 9, 2009 | Form 4 ↗ |
| SHAW DAVID E10% owner | Sale | −489.6K | $17.05 | $8.3M | 12.3Mdirect | Mar 6, 2009 | Mar 9, 2009 | Form 4 ↗ |
| SHAW DAVID E10% owner | Sale | −331.6K | $17.20 | $5.7M | 12.8Mdirect | Mar 5, 2009 | Mar 9, 2009 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −400 | $23.42 | $9K | 173.4Kdirect | Aug 12, 2008 | Aug 12, 2008 | Form 4 ↗ |
| Scodari Joseph CDirector | Purchase | +2,150 | $23.02 | $49K | 4,268direct | Aug 4, 2008 | Aug 4, 2008 | Form 4 ↗ |
| MANOGUE CAROLINE BExec. V.P., CLO & Secy | Sale | −59.7K | $34.90 | $2.1M | 293.7Kdirect | Jul 3, 2007 | Jul 6, 2007 | Form 4 ↗ |
| LANKAU PETER APresident & CEO · Director | Sale | −43.7K | $27.51 | $1.2M | 939.3Kdirect | Dec 4, 2006 | Dec 5, 2006 | Form 4 ↗ |
| AMMON CAROL ADirector | Sale | −809.9K | $25.60 | $20.7M | 603.6Kindirect | Nov 29, 2006 | Nov 29, 2006 | Form 4 ↗ |
| LANKAU PETER APresident & CEO · Director | Sale | −43.7K | $28.54 | $1.2M | 982.9Kdirect | Nov 1, 2006 | Nov 3, 2006 | Form 4 ↗ |
| LANKAU PETER APresident & CEO · Director | Sale | −43.7K | $29.80 | $1.3M | 1.0Mdirect | Oct 23, 2006 | Oct 25, 2006 | Form 4 ↗ |
| LANKAU PETER APresident & CEO · Director | Sale | −43.7K | $32.87 | $1.4M | 1.1Mdirect | Sep 1, 2006 | Sep 7, 2006 | Form 4 ↗ |
| LANKAU PETER APresident & CEO · Director | Sale | −43.7K | $31.36 | $1.4M | 1.2Mdirect | Aug 1, 2006 | Aug 4, 2006 | Form 4 ↗ |
| LANKAU PETER APresident & CEO · Director | Sale | −43.7K | $30.29 | $1.3M | 1.2Mdirect | Jul 24, 2006 | Jul 26, 2006 | Form 4 ↗ |
| LANKAU PETER APresident & CEO · Director | Sale | −43.7K | $29.60 | $1.3M | 1.2Mdirect | Jun 1, 2006 | Jun 5, 2006 | Form 4 ↗ |
| LANKAU PETER APresident & CEO · Director | Sale | −43.7K | $32.37 | $1.4M | 1.2Mdirect | May 1, 2006 | May 3, 2006 | Form 4 ↗ |
| LANKAU PETER APresident & CEO · Director | Sale | −43.7K | $31.56 | $1.4M | 1.3Mdirect | Apr 24, 2006 | Apr 25, 2006 | Form 4 ↗ |
| LEE DAVID A HExec. V.P and CSO | Sale | −233.4K | $31.65 | $7.4M | 185.8Kdirect | Mar 27, 2006 | Aug 9, 2006 | Form 4 ↗ |
| LEE DAVID A HExec. V.P and CSO | Sale | −235.3K | $31.65 | $7.4M | 0direct | Mar 27, 2006 | Aug 9, 2006 | Form 4 ↗ |
| AMMON CAROL ADirector | Sale | −1.2M | $31.65 | $39.5M | 0direct | Mar 27, 2006 | Aug 9, 2006 | Form 4 ↗ |
| CLINGEN BRIAN T | Sale | −3,750 | $31.65 | $119K | 16.3Kdirect | Mar 27, 2006 | Mar 29, 2006 | Form 4 ↗ |
| MITCHELL MICHAEL W | Sale | −7,500 | $31.65 | $237K | 13.8Kdirect | Mar 27, 2006 | Mar 29, 2006 | Form 4 ↗ |
| O DONNELL JOSEPH T JRDirector | Sale | −15.0K | $31.65 | $475K | 35.0Kdirect | Mar 27, 2006 | Mar 29, 2006 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −70.0K | $31.65 | $2.2M | 198.7Kindirect | Mar 27, 2006 | Mar 29, 2006 | Form 4 ↗ |
| LANKAU PETER APresident & CEO · Director | Sale | −43.7K | $31.93 | $1.4M | 1.3Mdirect | Mar 1, 2006 | Mar 3, 2006 | Form 4 ↗ |
| MITCHELL MICHAEL WDirector | Sale | −18.8K | $27.52 | $516K | 0direct | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| CLINGEN BRIAN TDirector | Sale | −5,000 | $27.52 | $138K | 0direct | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −16.3K | $27.52 | $447K | 23.7Kdirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −148.0K | $27.52 | $4.1M | 210.0Kindirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| HYATT MICHAELDirector | Sale | −25.0K | $27.52 | $688K | 25.0Kindirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| HYATT MICHAELDirector | Sale | −175.0K | $27.52 | $4.8M | 225.0Kdirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| MANOGUE CAROLINE BExec. V.P., CLO & Secy | Sale | −42.0K | $27.52 | $1.2M | 30.8Kdirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| LEE DAVID A HExec. V.P and CSO | Sale | −755.4K | $27.52 | $20.8M | 419.2Kdirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| LANKAU PETER APresident & CEO · Director | Sale | −33.0K | $27.52 | $909K | 23.7Kdirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| BLACK JEFFREY RExec. V.P., CFO and Treasurer | Sale | −669.4K | $27.52 | $18.4M | 358.5Kdirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| AMMON CAROL ADirector | Sale | −2.0M | $27.52 | $56.0M | 703.6Kdirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| Connors James J II10% owner | Sale | −7.3M | $27.52 | $201.1M | 8.3Mindirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| Loverro Frank JDirector · 10% owner | Sale | −7.9M | $27.52 | $217.9M | 9.0Mindirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| Loverro Frank JDirector · 10% owner | Sale | −7.9M | $27.52 | $217.9M | 9.0Mindirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| KELSO PARTNERS V L P10% owner | Sale | −7.2M | $27.52 | $198.8M | 8.2Mindirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| Connors James J II10% owner | Sale | −7.8M | $27.52 | $215.5M | 8.9Mindirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| WAHRHAFTIG DAVID IDirector · 10% owner | Sale | −7.8M | $27.52 | $215.5M | 8.9Mindirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| ENDO PHARMA LLC10% owner | Sale | −9.4M | $27.52 | $257.8M | 10.6Mdirect | Jan 24, 2006 | Jan 26, 2006 | Form 4 ↗ |
| KIMMEL ROGER HDirector | Sale | −26.1K | $32.00 | $836K | 448.0Kindirect | Jan 4, 2006 | Jan 6, 2006 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →